UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis

Journal of allergy and clinical immunology, 2007-06, Vol.119 (6), p.1430-1437

2007

Link zum Volltext

Verfügbarkeit prüfen

Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review

ERJ open research, 2021-01, Vol.7 (1), p.235

2021

Link zum Volltext

Verfügbarkeit prüfen

An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis

Allergy and asthma proceedings, 2010-11, Vol.31 (6), p.483

2010

Link zum Volltext

Verfügbarkeit prüfen

Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: A randomized, multicenter, double-blind, single-dose, crossover study

Clinical therapeutics, 2008-02, Vol.30 (2), p.271-279

2008

Link zum Volltext

Verfügbarkeit prüfen

Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment

Allergy and asthma proceedings, 2009-03, Vol.30 (2), p.120

2009

Link zum Volltext

Verfügbarkeit prüfen

Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents

Allergy and asthma proceedings, 2007-03, Vol.28 (2), p.216

2007

Link zum Volltext

Verfügbarkeit prüfen

No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray

American journal of rhinology & allergy, 2012-01, Vol.26 (1), p.36-44

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms

Annals of allergy, asthma, & immunology, 2006-06, Vol.96 (6), p.851-857

2006

Link zum Volltext

Verfügbarkeit prüfen

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast

Annals of allergy, asthma, & immunology, 2003-05, Vol.90 (5), p.536-542

2003

Link zum Volltext

Verfügbarkeit prüfen

No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year

Allergy and asthma proceedings, 2002-11, Vol.23 (6), p.407

2002

Link zum Volltext

Verfügbarkeit prüfen

Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy

Allergy and asthma proceedings, 2009-03, Vol.30 (2), p.128

2009

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis

Allergy and asthma proceedings, 2003-09, Vol.24 (5), p.331

2003

Link zum Volltext

Verfügbarkeit prüfen

Safety of second generation antihistamines

Allergy and asthma proceedings, 2000-01, Vol.21 (1), p.15

Philpot, E E

2000

Link zum Volltext

Verfügbarkeit prüfen

Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients

Pediatrics (Evanston), 2003-07, Vol.112 (1 Pt 1), p.96

2003

Link zum Volltext

Verfügbarkeit prüfen

Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn)

Annals of allergy, asthma, & immunology, 2003-07, Vol.91 (1), p.44-48

2003

Link zum Volltext

Verfügbarkeit prüfen

Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis?

Allergy and asthma proceedings, 2009-03, Vol.30 (2), p.212

2009

Link zum Volltext

Verfügbarkeit prüfen

Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function

Allergy and asthma proceedings, 2004-03, Vol.25 (2), p.115

2004

Link zum Volltext

Verfügbarkeit prüfen

Obstructive sleep apnea, nasal congestion, and snoring: their systemic effects and impact on quality of life

Allergy and asthma proceedings, 2004-01, Vol.25 (1), p.43

2004

Link zum Volltext

Verfügbarkeit prüfen

Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis

Allergy and asthma proceedings, 2002-07, Vol.23 (4), p.259

2002

Link zum Volltext

Verfügbarkeit prüfen

Reader's response to "comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?"

Medscape general medicine, 2006-04, Vol.8 (2), p.3; author reply 2

Philpot, Edward E

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of sedating and nonsedating antihistamines on flying performance

Military medicine, 1993-10, Vol.158 (10), p.654

1993

Link zum Volltext

Verfügbarkeit prüfen

Fluticasone Propionate Nasal Spray Is Superior to Montelukast for Allergic Rhinitis While Neither Affects Overall Asthma Control

Chest, 2005-10, Vol.128 (4), p.1910-1920

2005

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle Risk Factor Study 2004-2006

Internal medicine journal, 2008-12, Vol.38 (12), p.879-886

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study

Annals of allergy, asthma, & immunology, 2010-04, Vol.104 (4), p.331-338

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Female
(19)
Male
(19)
Androstadienes - Administration & Dosage
(17)
Allergy
(16)
Adult
(15)
Fluticasone
(14)
Double-Blind Method
(13)
Rhinitis, Allergic, Seasonal - Drug Therapy
(13)
Administration, Intranasal
(12)
Androstadienes - Adverse Effects
(12)
Middle Aged
(11)
Anti-Allergic Agents - Administration & Dosage
(10)
Treatment Outcome
(10)
Adolescent
(8)
Biological And Medical Sciences
(8)
Child
(8)
Medical Sciences
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis

Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis

Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: A randomized, multicenter, double-blind, single-dose, crossover study

Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment

Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents

No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast

No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year

Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy

The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis

Safety of second generation antihistamines

Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients

Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn)

Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis?

Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function

Obstructive sleep apnea, nasal congestion, and snoring: their systemic effects and impact on quality of life

Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis

Reader's response to "comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?"

Effects of sedating and nonsedating antihistamines on flying performance

Fluticasone Propionate Nasal Spray Is Superior to Montelukast for Allergic Rhinitis While Neither Affects Overall Asthma Control

Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle Risk Factor Study 2004-2006

Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study

Suchergebnisse filtern